Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cantor Fitzgerald
Medtronic
Covington
Chubb
Argus Health
Johnson and Johnson
Mallinckrodt
US Department of Justice
UBS
McKesson

Generated: January 21, 2018

DrugPatentWatch Database Preview

Naproxen sodium - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for naproxen sodium and what is the scope of naproxen sodium freedom to operate?

Naproxen sodium
is the generic ingredient in eight branded drugs marketed by Bionpharma Inc, Alvogen Malta, Actavis Labs Fl Inc, Bayer, Atnahs Pharma Us, Able, Amneal Pharms Ny, Aurobindo Pharma Ltd, Contract Pharmacal, Dr Reddys Labs Inc, Dr Reddys Labs Ltd, Glenmark Pharms Ltd, Granules India, Hamilton Pharms, Hikma, Ivax Sub Teva Pharms, Lnk Intl Inc, Marksans Pharma, Mylan, Perrigo, Pliva, Purepac Pharm, Roxane, Sandoz, Sun Pharm Inds Ltd, Teva, Teva Pharms, Watson Labs, and Pernix Ireland Ltd, and is included in thirty-nine NDAs. There are seven patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Naproxen sodium has fifteen patent family members in thirteen countries.

There are forty-two drug master file entries for naproxen sodium. One hundred and fifty-six suppliers are listed for this compound.
Pharmacology for naproxen sodium

US Patents and Regulatory Information for naproxen sodium

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Aurobindo Pharma Ltd NAPROXEN SODIUM naproxen sodium TABLET;ORAL 200629-002 Oct 31, 2011 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Hamilton Pharms NAPROXEN SODIUM naproxen sodium TABLET;ORAL 074106-001 Aug 31, 1993 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Able NAPROXEN SODIUM naproxen sodium TABLET;ORAL 076544-001 Aug 22, 2003 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Dr Reddys Labs Inc NAPROXEN SODIUM naproxen sodium TABLET;ORAL 075168-001 Jul 28, 1998 OTC No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Teva NAPROXEN SODIUM naproxen sodium TABLET;ORAL 074198-002 Dec 21, 1993 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Teva Pharms NAPROXEN SODIUM naproxen sodium TABLET;ORAL 074289-002 Jan 27, 1994 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Pernix Ireland Ltd TREXIMET naproxen sodium; sumatriptan succinate TABLET;ORAL 021926-001 Apr 15, 2008 RX Yes Yes ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Bayer ALEVE naproxen sodium TABLET;ORAL 020204-002 Jan 11, 1994 OTC Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Hamilton Pharms NAPROXEN SODIUM naproxen sodium TABLET;ORAL 074106-002 Aug 31, 1993 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Pernix Ireland Ltd TREXIMET naproxen sodium; sumatriptan succinate TABLET;ORAL 021926-002 May 14, 2015 RX Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for naproxen sodium

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Atnahs Pharma Us ANAPROX naproxen sodium TABLET;ORAL 018164-001 Approved Prior to Jan 1, 1982 ➤ Subscribe ➤ Subscribe
Alvogen Malta NAPRELAN naproxen sodium TABLET, EXTENDED RELEASE;ORAL 020353-001 Jan 5, 1996 ➤ Subscribe ➤ Subscribe
Atnahs Pharma Us ANAPROX DS naproxen sodium TABLET;ORAL 018164-003 Sep 30, 1987 ➤ Subscribe ➤ Subscribe
Alvogen Malta NAPRELAN naproxen sodium TABLET, EXTENDED RELEASE;ORAL 020353-002 Jan 5, 1996 ➤ Subscribe ➤ Subscribe
Atnahs Pharma Us ANAPROX naproxen sodium TABLET;ORAL 018164-001 Approved Prior to Jan 1, 1982 ➤ Subscribe ➤ Subscribe
Atnahs Pharma Us ANAPROX naproxen sodium TABLET;ORAL 018164-001 Approved Prior to Jan 1, 1982 ➤ Subscribe ➤ Subscribe
Alvogen Malta NAPRELAN naproxen sodium TABLET, EXTENDED RELEASE;ORAL 020353-003 Jan 5, 1996 ➤ Subscribe ➤ Subscribe
Atnahs Pharma Us ANAPROX DS naproxen sodium TABLET;ORAL 018164-003 Sep 30, 1987 ➤ Subscribe ➤ Subscribe
Atnahs Pharma Us ANAPROX DS naproxen sodium TABLET;ORAL 018164-003 Sep 30, 1987 ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents for naproxen sodium

Supplementary Protection Certificates for naproxen sodium

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
2012 00035 Denmark ➤ Subscribe PRODUCT NAME: ET KOMBINATIONSPRODUKT AF NAPROXEN OG ESOMEPRAZOL MAGNESIUM TRIHYDRAT; NAT. REG. NO/DATE: 49583 20120327; FIRST REG. NO/DATE: GB PL 17901/0263-001 20101105
2011005 Lithuania ➤ Subscribe PRODUCT NAME: NAPROXENUM + ESOMEPRAZOLUM; REGISTRATION NO/DATE: LT/1/10/2302/001-LT/1/10/2302/012 20110126
2011005,C0984957 Lithuania ➤ Subscribe PRODUCT NAME: NAPROXENUM + ESOMEPRAZOLUM; REGISTRATION NO/DATE: LT/1/10/2302/001-LT/1/10/2302/012 20110126
11/016 Ireland ➤ Subscribe PRODUCT NAME: NAPROXEN AND ESOMEPRAZOLE MODIFIED-RELEASE TABLETS; NAT REGISTRATION NO/DATE: PA0970/060/001 20101221; FIRST REGISTRATION NO/DATE: PL17901/0263-0001 20101105
2012000051 Germany ➤ Subscribe PRODUCT NAME: KOMBINATIONSPRODUKT UMFASSEND NAPROXEN UND ESOMEPRAZOL-MAGNESIUM-TRIHYDRAT; NAT. REGISTRATION NO/DATE: 85145.00.00 20120202; FIRST REGISTRATION: GROSSBRITANNIEN PL 17901/0263 - 0001 20101105
00481 Netherlands ➤ Subscribe PRODUCT NAME: NAPROXEN EN ESOMEPRAZOL; NAT. REGISTRATION NO/DATE: RVG 106235 20101118; FIRST REGISTRATION: PL 17901/0263-001 20101105
1411900/01 Switzerland ➤ Subscribe PRODUCT NAME: ESOMEPRAZOL + NAPROXEN; REGISTRATION NO/DATE: SWISSMEDIC 61330 06.05.2011
90013-1 Sweden ➤ Subscribe PRODUCT NAME: NAPROXEN OCH ESOMEPRAZOL; NAT. REG. NO/DATE: MTNR 43248 20101203; FIRST REG.: GB PL 17901/0263 20101105
C/GB11/015 United Kingdom ➤ Subscribe PRODUCT NAME: NAPROXEN AND ESOMEPRAZOLE; REGISTERED: UK PL 17901/0263-0001 20101105
C/GB11/013 United Kingdom ➤ Subscribe PRODUCT NAME: NAPROXEN AND ESOMEPRAZOLE; REGISTERED: UK PL 17901/0263-0001 20101105
Supplementary Protection Certificate SPC Country SPC Expiration SPC Description

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Citi
Covington
Express Scripts
Harvard Business School
Baxter
Moodys
Daiichi Sankyo
Dow
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot